Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000012915 | SCV001554546 | pathogenic | Carnitine acylcarnitine translocase deficiency | 2021-03-17 | criteria provided, single submitter | clinical testing | Variant summary: SLC25A20 c.897dupC (p.Asn300GlnfsX24) causes a frameshift which results in an extension of the protein. The variant allele was found at a frequency of 4e-06 in 250746 control chromosomes. c.897dupC has been reported in the literature in at-least two homozygous individuals affected with Carnitine-Acylcarnitine Translocase Deficiency and subsequently cited by others (example, Huizing_1997, Wang_2011, Ijlst_2001, Costa_2003, Palmieri_2020). These data indicate that the variant is likely to be associated with disease. At least two publications report experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in non-detectable to 10% of normal carnitine acylcarnitine translocase (CACT) activity (example, Huizing_1997, IJlst_2001). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic. |
Labcorp Genetics |
RCV000012915 | SCV002243100 | pathogenic | Carnitine acylcarnitine translocase deficiency | 2023-02-16 | criteria provided, single submitter | clinical testing | This variant is present in population databases (no rsID available, gnomAD 0.0009%). For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this frameshift affects SLC25A20 function (PMID: 11162577). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. ClinVar contains an entry for this variant (Variation ID: 12132). This variant is also known as 955-959insC. This frameshift has been observed in individual(s) with carnitine-acylcarnitine translocase deficiency (PMID: 9399886; Invitae). This sequence change results in a frameshift in the SLC25A20 gene (p.Asn300Glnfs*24). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 2 amino acid(s) of the SLC25A20 protein and extend the protein by 21 additional amino acid residues. |
OMIM | RCV000012915 | SCV000033156 | pathogenic | Carnitine acylcarnitine translocase deficiency | 1997-12-01 | no assertion criteria provided | literature only |